A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 56, Issue 4, 2008, Pages 772-774

  Devi, Gayatri ^a,b,c   Schultz, Sarah ^a   Khosrowshahi, Lynn ^a   Agnew, Abby ^a   Olali, Esther ^a  

^a New York Memory and Healthy Aging Services   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; POLYCLONAL ANTIBODY;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LETTER; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL;

AGED; ALZHEIMER DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 41549090910     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01620.x     Document Type: Letter

References (10)

1. Yaari R, Corey-Bloom J. Alzheimer's disease. Semin Neurol 2007 27 : 32 41.
2. Hyman BT. New neuropathological criteria for Alzheimer disease. Arch Neurol 1998 55 : 1174 1176.
3. Kennedy GJ, Golde TE, Tariot PN et al. Amyloid-Based interventions in Alzheimer's disease. CNS Spectr 2007 12 : 1 14.
4. Dodel RC, Du Y, Depboylu C et al. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004 75 : 1472 1474.
5. Relkin NR, Younkin L, Younkin S et al. Decreased plasma beta amyloid levels in Alzheimer patients treated chronically with Intravenous immunoglobulin (IVIG) [Abstract]. Alzheimer Dement 2006 2 : S590.
6. Weksler ME. The immunotherapy of Alzheimer's disease. Immun Ageing 2004 1 : 2.
7. Dodel R, Hampel H, Depboylu C et al. Human antibodies against amyloid peptide: A potential treatment for Alzheimer's disease. Ann Neurol 2002 52 : 253 256.
8. McKhann G, Drachmann D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984 34 : 939 944.
9. Kraszpulski M, Soininen H, Helisalmi S et al. The load and distribution of β-amyloid in brain tissue of patients with Alzheimer's disease. Acta Neurol Scand 2001 103 : 88 92.
10. Schafer S, Wirths O, Multhaup G et al. Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm 2007 114 : 387 394.